RECRUITING

Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this operational research study is to develop, implement and test integrated CCS\&PT and voluntary FP service delivery models to evaluate whether integrated service delivery can optimize uptake and health impact of both services. The study objectives and learning questions are listed below, along with key outcomes that will be measured.

Official Title

Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique

Quick Facts

Study Start:2020-12-22
Study Completion:2027-02-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05359016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:30 Years to 49 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Women 30 - 49 years or all women living with HIV
  2. * Not currently pregnant
  3. * Patients with a cervix (women who have undergone a total hysterectomy with removal of the cervix are not eligible)
  4. * Living in Maputo or Gaza
  5. * Willing and able to provide informed consent for services.
  1. * Not meeting the inclusion criteria
  2. * Physical or mental impairment that inhibits participation in the study
  3. * Pregnant women

Contacts and Locations

Study Contact

Mila Salecedo, MD, PHD
CONTACT
832-696-6794
mpsalcedo@mdanderson.org

Principal Investigator

Kathleen Schmeler, MD
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

M D Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Kathleen Schmeler, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-12-22
Study Completion Date2027-02-02

Study Record Updates

Study Start Date2020-12-22
Study Completion Date2027-02-02

Terms related to this study

Additional Relevant MeSH Terms

  • Cervical Cancer